VJOncology
@vjoncology.bsky.social
The Video Journal of Oncology is dedicated to providing up-to-date information & international expertise 🩺 🎥 🗞️
#BCsm #LCsm #GUsm #GIsm #PCsm #CRCsm
#BCsm #LCsm #GUsm #GIsm #PCsm #CRCsm
🔬 GI Cancer Sessions from #ASCO25!
Leading UCLA Health experts discuss breakthrough trials in GI oncology from #ASCO25
🌟 CHALLENGE (exercise improves colon cancer outcomes)
🌟 ATOMIC (MSI-high immunotherapy)
🌟MATTERHORN (gastric cancer advances)
Watch now: buff.ly/Tc81S2w
@ASCO #GCsm #GIsm #CRC
Leading UCLA Health experts discuss breakthrough trials in GI oncology from #ASCO25
🌟 CHALLENGE (exercise improves colon cancer outcomes)
🌟 ATOMIC (MSI-high immunotherapy)
🌟MATTERHORN (gastric cancer advances)
Watch now: buff.ly/Tc81S2w
@ASCO #GCsm #GIsm #CRC
August 5, 2025 at 2:54 PM
NEW #VJOncoAlert Journal Club with @oncoalert.bsky.social
Tackling "unresectable" high-risk stage III #NSCLC with Biagio Ricciuti from @danafarbernews.bsky.social
Watch 📹: tinyurl.com/ev5usd29
Read 🔖: tinyurl.com/3jafzs23
#LungCancer #LCsm
Tackling "unresectable" high-risk stage III #NSCLC with Biagio Ricciuti from @danafarbernews.bsky.social
Watch 📹: tinyurl.com/ev5usd29
Read 🔖: tinyurl.com/3jafzs23
#LungCancer #LCsm
July 31, 2025 at 2:03 PM
NEW #VJOncoAlert Journal Club with @oncoalert.bsky.social
Tackling "unresectable" high-risk stage III #NSCLC with Biagio Ricciuti from @danafarbernews.bsky.social
Watch 📹: tinyurl.com/ev5usd29
Read 🔖: tinyurl.com/3jafzs23
#LungCancer #LCsm
Tackling "unresectable" high-risk stage III #NSCLC with Biagio Ricciuti from @danafarbernews.bsky.social
Watch 📹: tinyurl.com/ev5usd29
Read 🔖: tinyurl.com/3jafzs23
#LungCancer #LCsm
🚨 NEW #VJOncoAlert Journal Club episode from
@vjoncology.bsky.social and @oncoalert.bsky.social 🚨
@silkegillessen.bsky.social discusses the addition of metformin to the SOC in mHSPC in the STAMPEDE trial!
📷Watch here: tinyurl.com/4knvf3ka
📔Read here: tinyurl.com/5fbjnsk3
@vjoncology.bsky.social and @oncoalert.bsky.social 🚨
@silkegillessen.bsky.social discusses the addition of metformin to the SOC in mHSPC in the STAMPEDE trial!
📷Watch here: tinyurl.com/4knvf3ka
📔Read here: tinyurl.com/5fbjnsk3
July 22, 2025 at 10:16 AM
🚨 NEW #VJOncoAlert Journal Club episode from
@vjoncology.bsky.social and @oncoalert.bsky.social 🚨
@silkegillessen.bsky.social discusses the addition of metformin to the SOC in mHSPC in the STAMPEDE trial!
📷Watch here: tinyurl.com/4knvf3ka
📔Read here: tinyurl.com/5fbjnsk3
@vjoncology.bsky.social and @oncoalert.bsky.social 🚨
@silkegillessen.bsky.social discusses the addition of metformin to the SOC in mHSPC in the STAMPEDE trial!
📷Watch here: tinyurl.com/4knvf3ka
📔Read here: tinyurl.com/5fbjnsk3
Expert-led Post-#ASCO2025 & #ESMOGI2025 Highlights webinars 💻📍
The #GICancer session will be chaired by
@lorenzarimassa.bsky.social & moderated by Richard Kim, Filippo Pietrantonio & Efrat Dotan
AGENDA 👉 buff.ly/NtN20KG
REGISTER 👉 buff.ly/4Z7VyTB
The #GICancer session will be chaired by
@lorenzarimassa.bsky.social & moderated by Richard Kim, Filippo Pietrantonio & Efrat Dotan
AGENDA 👉 buff.ly/NtN20KG
REGISTER 👉 buff.ly/4Z7VyTB
July 20, 2025 at 8:01 AM
Expert-led Post-#ASCO2025 & #ESMOGI2025 Highlights webinars 💻📍
The #GICancer session will be chaired by
@lorenzarimassa.bsky.social & moderated by Richard Kim, Filippo Pietrantonio & Efrat Dotan
AGENDA 👉 buff.ly/NtN20KG
REGISTER 👉 buff.ly/4Z7VyTB
The #GICancer session will be chaired by
@lorenzarimassa.bsky.social & moderated by Richard Kim, Filippo Pietrantonio & Efrat Dotan
AGENDA 👉 buff.ly/NtN20KG
REGISTER 👉 buff.ly/4Z7VyTB
⌛The wait is nearly over! #ASCO25 commences tomorrow!
Head to ➡️ VJOncology.com ⬅️ for up-to-date, exclusive coverage of the meeting and interviews with fantastic #Oncology experts!
@ascocancer.bsky.social
Head to ➡️ VJOncology.com ⬅️ for up-to-date, exclusive coverage of the meeting and interviews with fantastic #Oncology experts!
@ascocancer.bsky.social
May 29, 2025 at 8:03 AM
⌛The wait is nearly over! #ASCO25 commences tomorrow!
Head to ➡️ VJOncology.com ⬅️ for up-to-date, exclusive coverage of the meeting and interviews with fantastic #Oncology experts!
@ascocancer.bsky.social
Head to ➡️ VJOncology.com ⬅️ for up-to-date, exclusive coverage of the meeting and interviews with fantastic #Oncology experts!
@ascocancer.bsky.social
Catch up on the latest breakthroughs in #Oncology with our expert-led Post-#ASCO2025 & #ESMOGI Highlights webinars💻📍
Charied by Prof. Eva Ciruelos, Prof. Noemí Reguart, Dr. Neera Agarwal, Dr Meredith McKean & Dr. Lorenza Rimassa
REGISTER 👉 buff.ly/d9jNmvO
Charied by Prof. Eva Ciruelos, Prof. Noemí Reguart, Dr. Neera Agarwal, Dr Meredith McKean & Dr. Lorenza Rimassa
REGISTER 👉 buff.ly/d9jNmvO
May 26, 2025 at 12:39 PM
Catch up on the latest breakthroughs in #Oncology with our expert-led Post-#ASCO2025 & #ESMOGI Highlights webinars💻📍
Charied by Prof. Eva Ciruelos, Prof. Noemí Reguart, Dr. Neera Agarwal, Dr Meredith McKean & Dr. Lorenza Rimassa
REGISTER 👉 buff.ly/d9jNmvO
Charied by Prof. Eva Ciruelos, Prof. Noemí Reguart, Dr. Neera Agarwal, Dr Meredith McKean & Dr. Lorenza Rimassa
REGISTER 👉 buff.ly/d9jNmvO
📢With the 2025 ASCO Annual Meeting only 1 week away, we’re gearing up to provide you exclusive, up-to-date coverage!
Join us at VJOncology.com for key updates on #Oncology innovation and research!
#ASCO25 @ascocancer.bsky.social
Join us at VJOncology.com for key updates on #Oncology innovation and research!
#ASCO25 @ascocancer.bsky.social
May 23, 2025 at 8:02 AM
📢With the 2025 ASCO Annual Meeting only 1 week away, we’re gearing up to provide you exclusive, up-to-date coverage!
Join us at VJOncology.com for key updates on #Oncology innovation and research!
#ASCO25 @ascocancer.bsky.social
Join us at VJOncology.com for key updates on #Oncology innovation and research!
#ASCO25 @ascocancer.bsky.social
📢We’re so excited! #ASCO25 begins next week!
From May 30th we’ll be interviewing #Oncology experts – to discover the latest in cancer treatment innovations head to ➡️VJOncology.com⬅️
@ascocancer.bsky.social
From May 30th we’ll be interviewing #Oncology experts – to discover the latest in cancer treatment innovations head to ➡️VJOncology.com⬅️
@ascocancer.bsky.social
May 20, 2025 at 8:02 AM
📢We’re so excited! #ASCO25 begins next week!
From May 30th we’ll be interviewing #Oncology experts – to discover the latest in cancer treatment innovations head to ➡️VJOncology.com⬅️
@ascocancer.bsky.social
From May 30th we’ll be interviewing #Oncology experts – to discover the latest in cancer treatment innovations head to ➡️VJOncology.com⬅️
@ascocancer.bsky.social
📢With the 2025 ASCO Annual Meeting only 2 weeks away, we’re gearing up to provide you exclusive, up-to-date coverage!
Join us at VJOncology.com for key updates on #Oncology innovation and research!
#ASCO25 @ascocancer.bsky.socia
Join us at VJOncology.com for key updates on #Oncology innovation and research!
#ASCO25 @ascocancer.bsky.socia
May 16, 2025 at 11:03 AM
📢With the 2025 ASCO Annual Meeting only 2 weeks away, we’re gearing up to provide you exclusive, up-to-date coverage!
Join us at VJOncology.com for key updates on #Oncology innovation and research!
#ASCO25 @ascocancer.bsky.socia
Join us at VJOncology.com for key updates on #Oncology innovation and research!
#ASCO25 @ascocancer.bsky.socia
Catch up on the latest breakthroughs in #Oncology with our expert-led Post-#ASCO2025 & #ESMOGI Highlights webinars💻📍
Charied by Prof. Eva Ciruelos, Prof. Noemí Reguart, Dr. Neera Agarwal, Dr Meredith McKean & Dr. Lorenza Rimassa
REGISTER 👉 buff.ly/d9jNmvO
Charied by Prof. Eva Ciruelos, Prof. Noemí Reguart, Dr. Neera Agarwal, Dr Meredith McKean & Dr. Lorenza Rimassa
REGISTER 👉 buff.ly/d9jNmvO
May 12, 2025 at 12:37 PM
Catch up on the latest breakthroughs in #Oncology with our expert-led Post-#ASCO2025 & #ESMOGI Highlights webinars💻📍
Charied by Prof. Eva Ciruelos, Prof. Noemí Reguart, Dr. Neera Agarwal, Dr Meredith McKean & Dr. Lorenza Rimassa
REGISTER 👉 buff.ly/d9jNmvO
Charied by Prof. Eva Ciruelos, Prof. Noemí Reguart, Dr. Neera Agarwal, Dr Meredith McKean & Dr. Lorenza Rimassa
REGISTER 👉 buff.ly/d9jNmvO
Catch up on the latest breakthroughs in #Oncology with our expert-led Post-#ASCO2025 & #ESMOGI Highlights webinars💻📍
Charied by Prof. Eva Ciruelos, Prof. Noemí Reguart, Dr. Neera Agarwal, Dr Meredith McKean & Dr. Lorenza Rimassa
REGISTER 👉 buff.ly/d9jNmvO
Charied by Prof. Eva Ciruelos, Prof. Noemí Reguart, Dr. Neera Agarwal, Dr Meredith McKean & Dr. Lorenza Rimassa
REGISTER 👉 buff.ly/d9jNmvO
April 28, 2025 at 2:54 PM
Catch up on the latest breakthroughs in #Oncology with our expert-led Post-#ASCO2025 & #ESMOGI Highlights webinars💻📍
Charied by Prof. Eva Ciruelos, Prof. Noemí Reguart, Dr. Neera Agarwal, Dr Meredith McKean & Dr. Lorenza Rimassa
REGISTER 👉 buff.ly/d9jNmvO
Charied by Prof. Eva Ciruelos, Prof. Noemí Reguart, Dr. Neera Agarwal, Dr Meredith McKean & Dr. Lorenza Rimassa
REGISTER 👉 buff.ly/d9jNmvO
Breaking down the latest in #oncology, every week🚨🗞️ @oncoalert.bsky.social
This week Brian Rini & Tom Powles will be discussing LITESPARK-005: #Health-related quality of life with #belzutifan vs #everolimus for advanced #renalcellcarcinoma
Look out for episode tomorrow
👉https://lnkd.in/e6kJyPMz
This week Brian Rini & Tom Powles will be discussing LITESPARK-005: #Health-related quality of life with #belzutifan vs #everolimus for advanced #renalcellcarcinoma
Look out for episode tomorrow
👉https://lnkd.in/e6kJyPMz
April 1, 2025 at 9:30 AM
Breaking down the latest in #oncology, every week🚨🗞️ @oncoalert.bsky.social
This week Brian Rini & Tom Powles will be discussing LITESPARK-005: #Health-related quality of life with #belzutifan vs #everolimus for advanced #renalcellcarcinoma
Look out for episode tomorrow
👉https://lnkd.in/e6kJyPMz
This week Brian Rini & Tom Powles will be discussing LITESPARK-005: #Health-related quality of life with #belzutifan vs #everolimus for advanced #renalcellcarcinoma
Look out for episode tomorrow
👉https://lnkd.in/e6kJyPMz
March is #ProstateCancerAwarenessMonth in the UK 🗓️
Umang Swami, MD, MS, University of Utah, discusses emerging #biomarkers for #targetedtherapies in patients with #metastatic hormone-sensitive #prostatecancer (mHSPC)🧪💡
👉 buff.ly/mEEvAHe
Umang Swami, MD, MS, University of Utah, discusses emerging #biomarkers for #targetedtherapies in patients with #metastatic hormone-sensitive #prostatecancer (mHSPC)🧪💡
👉 buff.ly/mEEvAHe
March 31, 2025 at 8:01 AM
March is #ProstateCancerAwarenessMonth in the UK 🗓️
Umang Swami, MD, MS, University of Utah, discusses emerging #biomarkers for #targetedtherapies in patients with #metastatic hormone-sensitive #prostatecancer (mHSPC)🧪💡
👉 buff.ly/mEEvAHe
Umang Swami, MD, MS, University of Utah, discusses emerging #biomarkers for #targetedtherapies in patients with #metastatic hormone-sensitive #prostatecancer (mHSPC)🧪💡
👉 buff.ly/mEEvAHe
We're thrilled to partner with @oncoalert.bsky.social to bring you the VJOncoAlert Journal Club - a weekly #videoseries where we dive into the most impactful #oncology papers with authors themselves🚨🗞️
Gain #expertinsights
👉https://www.vjoncology.com/video/ayudqcnpedm-top-advances-in-sclc/
Gain #expertinsights
👉https://www.vjoncology.com/video/ayudqcnpedm-top-advances-in-sclc/
March 27, 2025 at 4:02 PM
We're thrilled to partner with @oncoalert.bsky.social to bring you the VJOncoAlert Journal Club - a weekly #videoseries where we dive into the most impactful #oncology papers with authors themselves🚨🗞️
Gain #expertinsights
👉https://www.vjoncology.com/video/ayudqcnpedm-top-advances-in-sclc/
Gain #expertinsights
👉https://www.vjoncology.com/video/ayudqcnpedm-top-advances-in-sclc/
March is #ProstateCancerAwarenessMonth in the UK📣
Omid Yazdanpanah, MD explores the potential of #radioligandtherapy combined with #androgen receptor pathway inhibitors (ARPIs) for #metastatic #castrationresistant #prostatecancer (mCRPC)🔬
👉 buff.ly/q8aQ75D
Omid Yazdanpanah, MD explores the potential of #radioligandtherapy combined with #androgen receptor pathway inhibitors (ARPIs) for #metastatic #castrationresistant #prostatecancer (mCRPC)🔬
👉 buff.ly/q8aQ75D
March 27, 2025 at 9:01 AM
March is #ProstateCancerAwarenessMonth in the UK📣
Omid Yazdanpanah, MD explores the potential of #radioligandtherapy combined with #androgen receptor pathway inhibitors (ARPIs) for #metastatic #castrationresistant #prostatecancer (mCRPC)🔬
👉 buff.ly/q8aQ75D
Omid Yazdanpanah, MD explores the potential of #radioligandtherapy combined with #androgen receptor pathway inhibitors (ARPIs) for #metastatic #castrationresistant #prostatecancer (mCRPC)🔬
👉 buff.ly/q8aQ75D
March is #ProstateCancerAwarenessMonth in UK📣
Did you know we have a #GUCancer channel? 🤔
Explore the latest updates presented at major international congresses in the form of #videointerviews, #podcasts & roundtable discussions feat. members of our expert Editorial Board 🎥🗞️
👉 buff.ly/eDDxupX
Did you know we have a #GUCancer channel? 🤔
Explore the latest updates presented at major international congresses in the form of #videointerviews, #podcasts & roundtable discussions feat. members of our expert Editorial Board 🎥🗞️
👉 buff.ly/eDDxupX
March 24, 2025 at 9:01 AM
March is #ProstateCancerAwarenessMonth in UK📣
Did you know we have a #GUCancer channel? 🤔
Explore the latest updates presented at major international congresses in the form of #videointerviews, #podcasts & roundtable discussions feat. members of our expert Editorial Board 🎥🗞️
👉 buff.ly/eDDxupX
Did you know we have a #GUCancer channel? 🤔
Explore the latest updates presented at major international congresses in the form of #videointerviews, #podcasts & roundtable discussions feat. members of our expert Editorial Board 🎥🗞️
👉 buff.ly/eDDxupX
It was great to catch up with Marleen Kok (@marleenkok.bsky.social) on #immunotherapy for ER+ #breastcancer and TNBC, and more at #SGBCC2025!
See who else we've been talking to on VJOncology.com to keep up to date on the latest in breast cancer 🖥️
#bcsm
See who else we've been talking to on VJOncology.com to keep up to date on the latest in breast cancer 🖥️
#bcsm
March 14, 2025 at 9:57 AM
It was great to catch up with Marleen Kok (@marleenkok.bsky.social) on #immunotherapy for ER+ #breastcancer and TNBC, and more at #SGBCC2025!
See who else we've been talking to on VJOncology.com to keep up to date on the latest in breast cancer 🖥️
#bcsm
See who else we've been talking to on VJOncology.com to keep up to date on the latest in breast cancer 🖥️
#bcsm
We had the opportunity to catch up with @tanjaspanic.bsky.social at #SGBCC2025, where she talked on tailoring therapies for early #breastcancer, and importance of survivorship and patient advocacy!
Visit VJOncology.com for exclusive interviews and more!
#bcsm
Visit VJOncology.com for exclusive interviews and more!
#bcsm
March 13, 2025 at 2:51 PM
We had the opportunity to catch up with @tanjaspanic.bsky.social at #SGBCC2025, where she talked on tailoring therapies for early #breastcancer, and importance of survivorship and patient advocacy!
Visit VJOncology.com for exclusive interviews and more!
#bcsm
Visit VJOncology.com for exclusive interviews and more!
#bcsm
Today is #InternationalWomensDay 💙
We'd like to thank all of the incredible women on our editorial board and within this field, who work hard to make a difference - from #researchers, to #clinicians, #nurses, #caretakers and more 👩⚕️🩺
Explore our disease channels 👉 buff.ly/K9zCF5H #IWD2025
We'd like to thank all of the incredible women on our editorial board and within this field, who work hard to make a difference - from #researchers, to #clinicians, #nurses, #caretakers and more 👩⚕️🩺
Explore our disease channels 👉 buff.ly/K9zCF5H #IWD2025
March 8, 2025 at 9:01 AM
Today is #InternationalWomensDay 💙
We'd like to thank all of the incredible women on our editorial board and within this field, who work hard to make a difference - from #researchers, to #clinicians, #nurses, #caretakers and more 👩⚕️🩺
Explore our disease channels 👉 buff.ly/K9zCF5H #IWD2025
We'd like to thank all of the incredible women on our editorial board and within this field, who work hard to make a difference - from #researchers, to #clinicians, #nurses, #caretakers and more 👩⚕️🩺
Explore our disease channels 👉 buff.ly/K9zCF5H #IWD2025
Missed out on #GU25?
Listen to our latest podcast, and to a preview below, where
@prof-nick-james.bsky.social discusses updates from the STAMPEDE trial, and the benefits of transdermal estradiol patches in #prostatecancer!
#kcsm #uroonc #blcsm #pcsm @icr.ac.uk @ascocancer.bsky.social
Listen to our latest podcast, and to a preview below, where
@prof-nick-james.bsky.social discusses updates from the STAMPEDE trial, and the benefits of transdermal estradiol patches in #prostatecancer!
#kcsm #uroonc #blcsm #pcsm @icr.ac.uk @ascocancer.bsky.social
February 21, 2025 at 10:12 AM
Missed out on #GU25?
Listen to our latest podcast, and to a preview below, where
@prof-nick-james.bsky.social discusses updates from the STAMPEDE trial, and the benefits of transdermal estradiol patches in #prostatecancer!
#kcsm #uroonc #blcsm #pcsm @icr.ac.uk @ascocancer.bsky.social
Listen to our latest podcast, and to a preview below, where
@prof-nick-james.bsky.social discusses updates from the STAMPEDE trial, and the benefits of transdermal estradiol patches in #prostatecancer!
#kcsm #uroonc #blcsm #pcsm @icr.ac.uk @ascocancer.bsky.social
Missed our #SkinCancer Session?
Worry not, as you can watch @drbetofmdphd.bsky.social, Omid Hamid & Inderjit Mehmi discuss therapeutic options for PD-1 refractory skin cancer on demand!!
Watch here 👉 www.vjoncology.com/event/skin-c... 👈
#Oncology #Melsm #Skcsm #melanoma
Worry not, as you can watch @drbetofmdphd.bsky.social, Omid Hamid & Inderjit Mehmi discuss therapeutic options for PD-1 refractory skin cancer on demand!!
Watch here 👉 www.vjoncology.com/event/skin-c... 👈
#Oncology #Melsm #Skcsm #melanoma
February 18, 2025 at 5:10 PM
Missed our #SkinCancer Session?
Worry not, as you can watch @drbetofmdphd.bsky.social, Omid Hamid & Inderjit Mehmi discuss therapeutic options for PD-1 refractory skin cancer on demand!!
Watch here 👉 www.vjoncology.com/event/skin-c... 👈
#Oncology #Melsm #Skcsm #melanoma
Worry not, as you can watch @drbetofmdphd.bsky.social, Omid Hamid & Inderjit Mehmi discuss therapeutic options for PD-1 refractory skin cancer on demand!!
Watch here 👉 www.vjoncology.com/event/skin-c... 👈
#Oncology #Melsm #Skcsm #melanoma
Had the pleasure to speak with @erplimackmd.bsky.social of Fox Chase Cancer Center at #GU25 on:
⭐OS results of CheckMate 274
⭐Additional NIAGARA findings
⭐RETAIN-2 of a risk-adapted approach for MIBC
⭐Phase I/II study of nivo and axitinib in RCC
#blcsm #kcsm #tscsm #uroonc @ascocancer.bsky.social
⭐OS results of CheckMate 274
⭐Additional NIAGARA findings
⭐RETAIN-2 of a risk-adapted approach for MIBC
⭐Phase I/II study of nivo and axitinib in RCC
#blcsm #kcsm #tscsm #uroonc @ascocancer.bsky.social
February 15, 2025 at 6:35 PM
Had the pleasure to speak with @erplimackmd.bsky.social of Fox Chase Cancer Center at #GU25 on:
⭐OS results of CheckMate 274
⭐Additional NIAGARA findings
⭐RETAIN-2 of a risk-adapted approach for MIBC
⭐Phase I/II study of nivo and axitinib in RCC
#blcsm #kcsm #tscsm #uroonc @ascocancer.bsky.social
⭐OS results of CheckMate 274
⭐Additional NIAGARA findings
⭐RETAIN-2 of a risk-adapted approach for MIBC
⭐Phase I/II study of nivo and axitinib in RCC
#blcsm #kcsm #tscsm #uroonc @ascocancer.bsky.social
Had the pleasure to catch up with @prof-nick-james.bsky.social of @icr.ac.uk talks on the STAMPEDE trial, which assessed tE2 patches in #prostatecancer, and the RAD-IO trial of durvalumab & chemo-RT in #bladdercancer
Visit VJOncology.com for more!
@ascocancer.bsky.social #GU25 #pcsm #blcsm #uroonc
Visit VJOncology.com for more!
@ascocancer.bsky.social #GU25 #pcsm #blcsm #uroonc
February 13, 2025 at 9:04 PM
Had the pleasure to catch up with @prof-nick-james.bsky.social of @icr.ac.uk talks on the STAMPEDE trial, which assessed tE2 patches in #prostatecancer, and the RAD-IO trial of durvalumab & chemo-RT in #bladdercancer
Visit VJOncology.com for more!
@ascocancer.bsky.social #GU25 #pcsm #blcsm #uroonc
Visit VJOncology.com for more!
@ascocancer.bsky.social #GU25 #pcsm #blcsm #uroonc
It was great to speak with Roger Li of @moffittnews.bsky.social on how ctDNA can improve staging of upper tract bladder cancer, and updates in BCG unresponsive NMIBC at #GU25.
Keep an eye out on our page for more interviews throughout the day!
@ascocancer.bsky.social #blcsm #uroonc
Keep an eye out on our page for more interviews throughout the day!
@ascocancer.bsky.social #blcsm #uroonc
February 13, 2025 at 5:51 PM
It was great to speak with Roger Li of @moffittnews.bsky.social on how ctDNA can improve staging of upper tract bladder cancer, and updates in BCG unresponsive NMIBC at #GU25.
Keep an eye out on our page for more interviews throughout the day!
@ascocancer.bsky.social #blcsm #uroonc
Keep an eye out on our page for more interviews throughout the day!
@ascocancer.bsky.social #blcsm #uroonc
We’re live in San Francisco covering the latest in #genitourinarycancer at #GU25 🌉
Keep an eye out for who we’ll be interviewing over the next few days and visit VJOnocology.com for exclusive videos, podcasts, and more!
@ascocancer.bsky.social #pcsm #blcsm #kcsm #tscsm #uroonc
Keep an eye out for who we’ll be interviewing over the next few days and visit VJOnocology.com for exclusive videos, podcasts, and more!
@ascocancer.bsky.social #pcsm #blcsm #kcsm #tscsm #uroonc
February 13, 2025 at 5:17 PM
We’re live in San Francisco covering the latest in #genitourinarycancer at #GU25 🌉
Keep an eye out for who we’ll be interviewing over the next few days and visit VJOnocology.com for exclusive videos, podcasts, and more!
@ascocancer.bsky.social #pcsm #blcsm #kcsm #tscsm #uroonc
Keep an eye out for who we’ll be interviewing over the next few days and visit VJOnocology.com for exclusive videos, podcasts, and more!
@ascocancer.bsky.social #pcsm #blcsm #kcsm #tscsm #uroonc